This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Sandoz Ag, Other. Active years: 2021-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 149 
1 out of 834,601 Years Active: 2021-2024
Title: Thomas Gelbrich: Innovator in Pharmaceutical Co-Crystals
Introduction
Thomas Gelbrich is a notable inventor based in Innsbruck, Austria. He has made significant contributions to the field of pharmaceuticals, particularly in the development of co-crystals that enhance the efficacy of various medications. With a total of 2 patents to his name, Gelbrich's work focuses on innovative solutions for treating medical conditions such as hypothyroidism and anemia.
Latest Patents
Gelbrich's latest patents include two groundbreaking inventions. The first patent involves co-crystals comprising levothyroxine and a dicarboxylic acid, specifically L-tartaric acid or oxalic acid. This invention not only details the composition of the co-crystals but also outlines a pharmaceutical formulation that can be utilized as a medicament for hypothyroidism. The second patent pertains to a co-crystal of roxadustat with L-proline, which is designed to treat and prevent anemia in patients suffering from end-stage renal disease (ESRD) and chronic kidney disease (CKD). This patent also includes a process for preparing the co-crystal and a pharmaceutical composition that incorporates it.
Career Highlights
Throughout his career, Thomas Gelbrich has worked with reputable companies, including Sandoz AG. His experience in the pharmaceutical industry has allowed him to develop innovative solutions that address critical health issues. His work has been instrumental in advancing the field of drug formulation and delivery.
Collaborations
Gelbrich has collaborated with esteemed colleagues such as Hannes Lengauer and Arthur Pichler. These partnerships have contributed to the successful development of his patented inventions and have fostered a collaborative environment for innovation.
Conclusion
Thomas Gelbrich stands out as a prominent inventor in the pharmaceutical sector, with a focus on co-crystals that enhance drug efficacy. His contributions are vital for the treatment of various medical conditions, showcasing the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile